The next-generation heart pump to change patients’ lives and create a new standard of care

Project description

A smart implantable pump for advanced heart failure

Heart failure is a life-threatening condition in which the heart is unable to pump enough blood to meet the needs of the body. For patients with advanced heart failure and who are either too old or not suitable for a heart transplant, implantable left ventricular assist devices (LVADs) have emerged as a new treatment option. The EU-funded Calypso project will bring to market a game-changing LVAD developed by the French CORWAVE company. This new device relies on a unique and patented breakthrough technology, the wave membrane. Unlike current devices, which are continuous-flow rotary pumps, CorWave LVAD is a smart pump producing a physiologic and pulsatile blood flow, to restore a normal life to patients with minimal side effects.

Fields of science

• medical and health sciences › basic medicine › neurology › stroke
• medical and health sciences › clinical medicine › cardiology

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

CORWAVE

Net EU contribution

€ 2 495 675,00

Address

17 Rue De Neuilly Impasse Passoir
92110 Nanterre
France

Region

Ile-de-France › Ile-de-France › Hauts-de-Seine

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 1 069 575,00